Alterations in Muscle After Total Knee Arthroplasty
7 de junio de 2021 actualizado por: University of Colorado, Denver
Alterations in Skeletal Muscle Gene Expression Following Total Knee Arthroplasty
The overall goals of this work are: 1) to elucidate alterations in gene expression and downstream protein synthesis 2 weeks after Total Knee Arthroplasty (TKA) to better explain quadriceps muscle atrophy after TKA and 2) understand the mechanisms responsible for improved maintenance of muscle strength with Neuromuscular Electrical Stimulation (NMES) utilization.
Furthermore, this investigation seeks to expand previous findings regarding attenuation of strength and functional performance deficits with NMES application to better understand how altered gene expression influences muscle function.
Descripción general del estudio
Estado
Terminado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Intervencionista
Inscripción (Anticipado)
20
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
Colorado
-
Aurora, Colorado, Estados Unidos, 80045
- University of Colorado School of Medicine
-
Aurora, Colorado, Estados Unidos, 80045
- Univeristy of Colorado Anschutz Medical Campus
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
50 años a 75 años (Adulto, Adulto Mayor)
Acepta Voluntarios Saludables
No
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- 50 to 75 years of age
- Scheduled for unilateral TKA at University of Colorado Hospital
- Diagnosed with osteoarthritis
- Cognitive status that allows patients to consistently comprehend and repeat back directions regarding the details of the study
Exclusion Criteria:
- Neurological, vascular or cardiac problems that significantly limit function
- BMI > 35
- Testosterone supplementation
- Pregnancy
- Anticoagulant therapy
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Neuromuscular Electrical Stimulation
Neuromuscular Electrical Stimulation (NMES) 48 hours after TKA, 5x/week, 2x/day, for 45 minutes/session. Standard Rehabilitation Protocol |
5x/week, 2x/day, for 45 minutes/session
Standard physical therapy after TKA
|
|
Comparador activo: Control
Standard Rehabilitation Protocol
|
Standard physical therapy after TKA
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Catabolic gene expression
Periodo de tiempo: Change in gene expression from immediately pre surgery to 2 weeks after surgery
|
Standard procedures including total RNA isolation, cDNA synthesis, cRNA labeling, microarray hybridization and image acquisition will be performed.
Protein content (translation of MAFbx, MuRF1, myostatin) will be analyzed.
Total RNA (500 ng) will be reverse transcribed with the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA), and quantitative PCR will be performed using primer sets for genes of interest, reference genes and iQ SYBR Supermix (Bio-Rad) following manufacturer's protocols.
|
Change in gene expression from immediately pre surgery to 2 weeks after surgery
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Changes in quadriceps strength
Periodo de tiempo: 3 days Pre operative and 2 weeks post operative
|
Isometric quadriceps strength will be using a doublet interpolation test performed by research assistants blinded to participants' treatment randomization.
Briefly, patients will be seated and stabilized in a HUMAC NORM (Computer Sports Medicine Incorporated, Stoughton, MA) dynamometer with their knee flexed to 60 degrees.
After proper warm up, patients will be asked to perform a maximum voluntary isometric contraction of their quadriceps while receiving verbal reinforcement.
|
3 days Pre operative and 2 weeks post operative
|
|
Changes in quadriceps size
Periodo de tiempo: 3 days Pre operative and 2 weeks post operative
|
Peripheral Quantitative Computed Tomography scans of the distal femur will be used to assess the changes in quadriceps muscle morphology quantitatively.
The maximal cross-sectional area of the quadriceps will be determined prior to TKA and ~14 days after TKA by manually placing the scanner at a line marked on the vastus lateralis one third of the distance between the greater trochanter and the lateral epicondyle of the femur.
The pQCT software will analyze the image and calculate muscle cross-sectional area.
A previous investigation by Cramer, et al. validated the pQCT to measurement of muscle cross-sectional area by comparison to MRI and (R2 values of 0.979 and 0.983).
In addition, the use of the pQCT to measure muscle cross sectional area had high test-retest reliability, with ICC values of 0.996 and 0.998.
|
3 days Pre operative and 2 weeks post operative
|
|
Changes in quadriceps activation
Periodo de tiempo: 3 days Pre operative and 2 weeks post operative
|
Isometric quadriceps activation testing will be using a doublet interpolation test performed by research assistants blinded to participants' treatment randomization.
Briefly, patients will be seated and stabilized in a HUMAC NORM (Computer Sports Medicine Incorporated, Stoughton, MA) dynamometer with their knee flexed to 60 degrees.
After proper warm up, patients will be asked to perform a maximum voluntary isometric contraction of their quadriceps while receiving verbal reinforcement.
During the contraction, a 2 pulse, 600 µs duration/pulse, supramaximal 100Hz stimulus will be delivered to the muscle to assess whether the subject is indeed maximally contracting the quadriceps muscle and again at rest.
|
3 days Pre operative and 2 weeks post operative
|
|
Functional Performance Measures (4 meter walk test, timed up and go, stair climbing test)
Periodo de tiempo: 3 days Pre operative and 2 weeks post operative
|
The timed Stair Climbing Test (SCT) places a high demand on the quadriceps and therefore measures a higher level of function and, therefore, minimizes the possibility of a ceiling effect.
The SCT has been shown to significantly correlate to the Timed Up and Go (TUG).
The TUG measures the time it takes a patient to rise from an arm chair (seat height of 46 cm), walk 3 m, turn and return to sitting in the same chair without physical assistance.25
This test has excellent inter-rater (ICC=0.99)
and intra-rater reliability (ICC=0.99),
as measured in a group of 60 functionally disabled older adults (mean age 80 years).25
The 4 meter Walk Test (4mWT) will be assessed at the fastest safe speed for each participant.
|
3 days Pre operative and 2 weeks post operative
|
|
Anabolic Gene Expression
Periodo de tiempo: Immediately pre surgery to 2 weeks after surgery
|
Standard procedures including total RNA isolation, cDNA synthesis, cRNA labeling, microarray hybridization and image acquisition will be performed.
Protein content (translation of mTOR, myogenin, and MyoD) will be analyzed.
Total RNA (500 ng) will be reverse transcribed with the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA), and quantitative PCR will be performed using primer sets for genes of interest, reference genes and iQ SYBR Supermix (Bio-Rad) following manufacturer's protocols.
|
Immediately pre surgery to 2 weeks after surgery
|
|
Muscle Fiber Cross-Sectional Area
Periodo de tiempo: Immediately pre surgery to 2 weeks after surgery
|
Cross sectional area of individual myofibrils taken from the vastus lateralis muscle using immunohistochemical staining and microscopy to determine change in cross sectional area comparing one hour before surgery to two weeks after surgery
|
Immediately pre surgery to 2 weeks after surgery
|
|
Changes in neural cell adhesion molecule (NCAM) concentration
Periodo de tiempo: Preop and 2 weeks postop
|
NCAM will be assessed by immunohistochemistry with anti-CD56/NCAM antibody (555514; BD Biosciences, San Jose, CA), followed by goat anti-mouse AF555 (A-21127, ThermoFisher).
NCAM is a multifunctional cell-surface protein that has been shown to be associated with muscle regeneration, through its roles in neurite outgrowth and synaptic plasticity.
NCAM immunohistochemistry will be able to assess 1) denervation status, 2) skeletal muscle response to an intervention, and 3) the capacity for skeletal muscle to improve.
|
Preop and 2 weeks postop
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Investigadores
- Investigador principal: Victor Cheuy, PhD, University of Colorado, Denver
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio
1 de octubre de 2014
Finalización primaria (Actual)
9 de marzo de 2020
Finalización del estudio (Actual)
9 de marzo de 2020
Fechas de registro del estudio
Enviado por primera vez
7 de octubre de 2014
Primero enviado que cumplió con los criterios de control de calidad
30 de octubre de 2014
Publicado por primera vez (Estimar)
4 de noviembre de 2014
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
9 de junio de 2021
Última actualización enviada que cumplió con los criterios de control de calidad
7 de junio de 2021
Última verificación
1 de junio de 2021
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 14-0905
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .